Yao Lihe, Hou Lijuan, Lao Yongfeng, Luo Wei, Lu Zhenxing, Chen Jun, Liu Yongming
Department of Neurology, The First Hospital of Lanzhou University.
Lanzhou University, First Clinical Medical College Lanzhou.
Medicine (Baltimore). 2020 Jul 17;99(29):e21265. doi: 10.1097/MD.0000000000021265.
To assess the dose-response relationship between alcohol consumption and the progression of MCI to dementia.
This study adheres to the Preferred Reporting Items for Systematic Reviews and Meta analysis for Protocols. Chinese Biomedical Literature Database (CBM), PubMed, Cochrane Library, EMBASE will be searched for all relevant published articles, with no restrictions on the year of publication or language. Case-control and cohort studies explored the relationship between alcohol exposure and the incidence of dementia in patients with MCI will be included. Study selection, data collection and assessment of study bias will be conducted independently at each level by a pair of independent reviewers. The Newcastle-Ottawa Scale (NOS) tool will be used for the risk of bias assessment. The methodological quality of systematic review will be based on A measurement Tool to Assess Systematic Review (AMSTAR 2). The Grading of Recommendations Assessment Development and Evaluation (GRADE) system will be used to assess the quality of evidence. Stata 15.0 will be used for general meta-analysis and exploring the dose-response relationship. Piecewise linear regression model and the restricted cubic spline model will be used for nonlinear trend estimation, and the generalized least-square method will be used to estimate the parameters.
This dose-response meta-analysis is the first to investigate the dose-effect relationship between alcohol exposure and the incidence of dementia in patients with MCI, providing a comprehensive understanding of the prevention of alcohol-related cognitive impairment.
The dose-response meta-analysis is registered in the PROSPERO (CRD42019127226) international prospective register of systematic review.
评估饮酒量与轻度认知障碍(MCI)进展为痴呆之间的剂量反应关系。
本研究遵循系统评价与Meta分析方案的首选报告项目。将检索中国生物医学文献数据库(CBM)、PubMed、Cochrane图书馆、EMBASE中所有相关已发表文章,对发表年份和语言均无限制。纳入探索酒精暴露与MCI患者痴呆发病率之间关系的病例对照研究和队列研究。由一对独立的评审员在每个层面独立进行研究选择、数据收集和研究偏倚评估。将使用纽卡斯尔-渥太华量表(NOS)工具进行偏倚风险评估。系统评价的方法学质量将基于评估系统评价的测量工具(AMSTAR 2)。将使用推荐分级评估、制定与评价(GRADE)系统评估证据质量。将使用Stata 15.0进行一般Meta分析并探索剂量反应关系。将使用分段线性回归模型和受限立方样条模型进行非线性趋势估计,并使用广义最小二乘法估计参数。
这项剂量反应Meta分析首次调查了酒精暴露与MCI患者痴呆发病率之间的剂量效应关系,为预防酒精相关认知障碍提供了全面的认识。
该剂量反应Meta分析已在PROSPERO(CRD42019127226)国际系统评价前瞻性注册库中注册。